Overall, the choice between Retatrutide and any of the other weight management peptides depends on individual needs and health goals
The SELECT cardiovascular outcomes trial established that semaglutide reduces major adverse cardiovascular events by 20%, providing a strong clinical rationale for treatment that extends beyond weight management alone
doi:10.1016/j.jacl.2021.09.049 Jiang L, Wang J, Xiong K, Xu L, Zhang B, Ma A
Although it varies by patient and depends on the particular dermal filler used, results from dermal filler injections are immediate and typically last for six to 24 months, depending upon the filler used and the area treated
J.BergensthlB.PurhagenJ.RojasC
More rarely, some users have reported suicidal ideations